Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.57 USD
Change Today -0.13 / -4.81%
Volume 1.8M
EXEL On Other Exchanges
As of 5:20 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael M. Morrissey Ph.D.

Chief Executive Officer, President and Director, Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Michael M. Morrissey, Ph.D. has been the Chief Executive Officer and President at Exelixis, Inc., since July 2010. Dr. Morrissey served as the President of Research and Development at Exelixis Inc., since January 4, 2007. Dr. Morrissey served as an Executive Vice President of Discovery of Exelixis Inc., from January 2006 to December 2006 and its Senior Vice President of Discovery Research from January 2003 to December 2005. Dr. Morrissey served as Vice President ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

Chief Executive Officer, President and Director


Harvard University
Concordia University, Wisconsin

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,104,003

Stock Options*

All Other Compensation$7,650
Exercisable Options1,544,375
Exercisable Options Value$234,172
Unexercisable Options1,202,625
Unexercisable Options Value$494,728
Total Value of Options$1,031,000
Total Number of Options3,495,000

Total Compensation*

Total Annual Cash Compensation$1,111,653
Total Short Term Compensation$1,104,003
Other Long Term Compensation$7,650
Total Calculated Compensation$4,825,413
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $2.57 USD -0.13


James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
Raul R. Rodriguez Chief Executive Officer, President and Director
Rigel Pharmaceuticals, Inc.
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at